New Market Research Report: Dermatologicals in Ireland

Dermatologicals in Ireland continues to benefit from the perception of these products as being essential in nature. Additionally, with the outwardly visible nature of skin symptoms it remains a category in which the products are considered with general urgency. Higher than average unit prices continue to support the value performance of the category, with many of the products only available through the pharmacy channel. This is bolstered by the tendency for consumers to seek the help of a pharmacist in relation to their skin conditions and to avail of the specialised and personal interaction offered within this channel.

Competitive Landscape

McNeil Healthcare (Ireland) Ltd remains the leading player in Ireland in 2015 with 20% value share. The company retains a strong and varied brand portfolio in dermatologicals with two brands, Anusol with an 8% value share and Regaine with a 5% share, appearing in the category’s top five brands in 2015. Additionally, Daktarin and Nizoral, both with a 2% value share in 2015, rank within the top 10. Meanwhile its Johnson’s Baby lotion and gel products are household names in Ireland. While the broad range of products presented by the company tend to be from more mature formulations they nevertheless remain very popular with consumers. Brand loyalty is a key feature within dermatologicals and in the case of these products it is exploited with great efficiency.

Full Report Details at
- http://www.fastmr.com/prod/1082183_dermatologicals_ireland.aspx?afid=301

Industry Prospects

Dermatologicals in Ireland is expected to increase in value at a CAGR of 1% in constant 2015 terms over the forecast period, in line with the performance seen during the review period. Consumers are expected to continue self-managing most skin conditions, and in doing so, continue to place their trust in the leading brands. Additionally, with a large number of products available only through pharmacies, unit prices are unlikely to come under significant pressure in spite of the growing prevalence of generic products. Brand loyalty should remain a prominent feature.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Ireland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Ireland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Ireland market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Dermatologicals in the United Arab Emirates
- Dermatologicals in Thailand
- Dermatologicals in Algeria
- Dermatologicals in Denmark
- Dermatologicals in Morocco